Certain types of diabetes medications known as DPP-4 inhibitors have recently been linked to severe side-effects. The prescription drug Onglyza is one of these types of medications. Some studies have linked these drugs to heart failure, pancreatitis, and pancreatic cancers. A new study seems to support the previous studies.
The diabetes drug Onglyza is also an antioxidant. For a long time now, health advocates have been championing antioxidants because they neutralize free radicals that can harm DNA. At least, the antioxidants that are found in certain foods can. However, supplement antioxidants have been disappointing in tests. A study published recently supports the idea that antioxidants can fuel the spread of cancer cells.
Researching scientists both in the United States and China found that two popular drugs for diabetes can actually speed cancer cell formation.
These scientists exposed lab dished of human cancer cells to the drugs Januvia and Onglyza, the cells migrated more. In lab mice with human tumors were given the drug, it was bad news. The cancer metastasized more and invaded tissue far from the initial tumor.
However, it must be noted that neither of the medications did not raise the risk of developing cancer.
In addition, a 2015 case report showed that a patient with a rare cancer had been given the drug Onglyza and experienced more serious metastasis.
If you have experienced complications or injury due to taking the prescribed drug Onglyza, you may be entitled to compensation. Contact the law offices of John Foy & Associates. The “Strong Arm” attorneys will work to get you the compensation you deserve. Contact us today.